Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
March 27, 2024 07:00 ET
|
Gamida Cell, Ltd
Company announces commencement of restructuring process supported by Highbridge Capital Management Continued progress of launch of Omisirge® (omidubicel-onlv), with the delivery of six units in 2023,...
Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
March 27, 2024 07:00 ET
|
Gamida Cell, Ltd
Company expected to receive significant new capital from Highbridge to bolster the commercialization of allogeneic stem cell transplant Omisirge® (omidubicel-onlv) Gamida Cell to become a private...
Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
March 22, 2024 08:00 ET
|
Gamida Cell, Ltd
BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its...
Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
February 23, 2024 08:00 ET
|
Gamida Cell, Ltd
Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and infections following stem cell transplant with Omisirge®...
Gamida Cell Actively Pursuing Strategic Alternatives
January 29, 2024 06:00 ET
|
Gamida Cell, Ltd
BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it is actively pursuing strategic...
Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
January 17, 2024 08:00 ET
|
Gamida Cell, Ltd
BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced it will present new data on its...
Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023
November 27, 2023 20:11 ET
|
Gamida Cell, Ltd
BOSTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, is hosting a virtual fireside chat with thought...
Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023 08:00 ET
|
Gamida Cell, Ltd
BOSTON, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that its management team will...
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
November 14, 2023 07:00 ET
|
Gamida Cell, Ltd
Company continues to advance launch, reports initial revenue from Omisirge® (omidubicel-onlv) Company to host conference call today at 8:30 a.m. ET BOSTON, Nov. 14, 2023 (GLOBE...
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 04, 2023 08:00 ET
|
Gamida Cell, Ltd
BOSTON, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the...